Smith and Nephew plc

Activities: Personal Protection Manufacturing Ingredients Medical Devices

Trending Articles

  1. Merck's sacituzumab tirumotecan granted Breakthrough Therapy Designation by the FDA The antibody-drug conjugate (ADC) can be used to treat patients with advanced or metastatic non-small cell lung cancer (NSCLC)
  2. Novavax sells protein manufacturing facility to Novo Nordisk for $200m Novo Nordisk's purchase of Novavax's Czech recombinant protein manufacturing facility will involve a full transfer of assets — including its workforce and associated support...
  3. Precision psychiatry in action: How IMed Consultancy helped HMNC Brain Health’s Cortibon programme AI-driven approach promises a new class of depression treatment
  4. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  5. ACG launches ADAPT X at CPhI & PMEC India 2024 Innovative tablet feeder sets new benchmarks for efficiency and versatility in pharmaceutical packaging solutions

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Manufacturing

Smith & Nephew grows surgical robotics offering

The British medical technology company has invested in its digital surgery portfolio through the acquisition of Brainlab’s Orthopaedic Joint Reconstruction business and the opening of a new R&D centre
Finance

Smith & Nephew acquires Osiris to focus on regenerative medicine

The companies expect to close the transaction in the second quarter of 2019, subject to customary closing conditions
Recruitment

Smith and Nephew appoints Namal Nawana CEO

Finance

Graham Baker appointed Chief Financial Officer

Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces the appointment of Graham Baker as Chief Financial Officer.
Subscribe now